Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of EUR 132.86 billion. The enterprise value is 176.54 billion.

Market Cap	132.86B
Enterprise Value	176.54B

Important Dates

The last earnings date was Thursday, May 1, 2025.

Earnings Date	May 1, 2025
Ex-Dividend Date	May 15, 2025

Share Statistics

Current Share Class	537.71M
Shares Outstanding	n/a
Shares Change (YoY)	+0.88%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	536.32M

Valuation Ratios

The trailing PE ratio is 24.20 and the forward PE ratio is 13.37.

PE Ratio	24.20
Forward PE	13.37
PS Ratio	4.21
PB Ratio	23.14
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.32, with an EV/FCF ratio of 17.48.

EV / Earnings	32.16
EV / Sales	5.75
EV / EBITDA	12.32
EV / EBIT	19.12
EV / FCF	17.48

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 9.24.

Current Ratio	1.17
Quick Ratio	0.74
Debt / Equity	9.24
Debt / EBITDA	3.60
Debt / FCF	5.26
Interest Coverage	2.88

Financial Efficiency

Return on equity (ROE) is 105.67% and return on invested capital (ROIC) is 9.67%.

Return on Equity (ROE)	105.67%
Return on Assets (ROA)	7.04%
Return on Invested Capital (ROIC)	9.67%
Return on Capital Employed (ROCE)	15.47%
Revenue Per Employee	1.13M
Profits Per Employee	196,043
Employee Count	28,000
Asset Turnover	0.37
Inventory Turnover	1.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.57%
50-Day Moving Average	270.65
200-Day Moving Average	280.06
Relative Strength Index (RSI)	42.58
Average Volume (20 Days)	109

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.68

Income Statement

In the last 12 months, Amgen had revenue of EUR 31.57 billion and earned 5.49 billion in profits. Earnings per share was 10.12.

Revenue	31.57B
Gross Profit	21.81B
Operating Income	9.50B
Pretax Income	6.15B
Net Income	5.49B
EBITDA	14.55B
EBIT	9.50B
Earnings Per Share (EPS)	10.12

Full Income Statement

Balance Sheet

The company has 8.15 billion in cash and 53.09 billion in debt, giving a net cash position of -44.94 billion.

Cash & Cash Equivalents	8.15B
Total Debt	53.09B
Net Cash	-44.94B
Net Cash Per Share	n/a
Equity (Book Value)	5.74B
Book Value Per Share	10.68
Working Capital	3.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.28 billion and capital expenditures -1.18 billion, giving a free cash flow of 10.10 billion.

Operating Cash Flow	11.28B
Capital Expenditures	-1.18B
Free Cash Flow	10.10B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.07%, with operating and profit margins of 30.08% and 17.39%.

Gross Margin	69.07%
Operating Margin	30.08%
Pretax Margin	19.49%
Profit Margin	17.39%
EBITDA Margin	46.08%
EBIT Margin	30.08%
FCF Margin	31.98%

Dividends & Yields

This stock pays an annual dividend of 6.25, which amounts to a dividend yield of 2.67%.

Dividend Per Share	6.25
Dividend Yield	2.67%
Dividend Growth (YoY)	6.12%
Years of Dividend Growth	4
Payout Ratio	82.64%
Buyback Yield	-0.88%
Shareholder Yield	1.78%
Earnings Yield	4.13%
FCF Yield	7.60%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.56. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.56
Piotroski F-Score	n/a